Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1028532 | 0.91 | MAP3K14 (0.40) | MAP3K14CRBNCYP19A1MEN1APEX1 | |
| SCHEMBL15494454 | 0.91 | — | — | |
| SCHEMBL31244467 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL3986242 | 0.88 | — | — | |
| Phosphine SCHEMBL22345181 | 0.88 | — | — | |
| Ammonia Solution, Strong SCHEMBL25176856 | 0.88 | — | — | |
| SCHEMBL320576 | 0.88 | — | — | |
| SCHEMBL114368 | 0.88 | MAP3K14 (0.38) | MAP3K14CRBNCYP19A1MEN1KMT2A | |
| SCHEMBL114518 | 0.86 | MAP3K14 (0.36) | MAP3K14CRBN | |
| Ethane SCHEMBL28857929 | 0.86 | MAP3K14 (0.46) | MAP3K14CRBNCYP19A1MEN1APEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115052868-A | Cannabinoid sulfate, and salts and uses thereof | 伦敦制药与研究公司 | 2022-09-13 | — | — | CN | claimed |
| EP-3215567-A1 | METHOD OF PRODUCTION OF GRAFT CO-POLYMER EXCIPIENT WITH A SUPERIOR PEPTIDE AND PROTEIN BINDING PROPERTY | Pharmain Corporation (US) | 2017-09-13 | — | — | EP | claimed |
| WO-2016073518-A1 | METHOD OF PRODUCTION OF GRAFT CO-POLYMER EXCIPIENT WITH A SUPERIOR PEPTIDE AND PROTEIN BINDING PROPERTY | PHARMAIN CORPORATION (US) | 2016-05-12 | — | — | WO | claimed |
| CN-115052868-A | Cannabinoid sulfate, and salts and uses thereof | 伦敦制药与研究公司 | 2022-09-13 | — | — | CN | disclosed |
| EP-1971372-A2 | HYDROPHOBIC CORE CARRIER COMPOSITIONS FOR DELIVERY OF THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THE SAME | Pharmain, Ltd. (US) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007076371-A2 | HYDROPHOBIC CORE CARRIER COMPOSITIONS FOR DELIVERY OF THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THE SAME | PHARMAIN CORPORATION (US) | 2007-07-05 | — | — | WO | disclosed |